Report Detail

Request for Sample of this report

Other Global Noninvasive Prenatal Diagnostics Market 2024 by Company, Regions, Type and Application, Forecast to 2030

  • RnM4603045
    • |
  • 20 July, 2024
    • |
  • Global
    • |
  • 108 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Other

According to our (Global Info Research) latest study, the global Noninvasive Prenatal Diagnostics market size was valued at USD 8680.7 million in 2023 and is forecast to a readjusted size of USD 19150 million by 2030 with a CAGR of 12.0% during review period.
Noninvasive Prenatal Diagnostics detect a variety of chromosomal disorders such as Down's syndrome, Edwards syndrome, Turner syndrome and Pato syndrome.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Noninvasive Prenatal Diagnostics industry chain, the market status of Hospital (Services, Instrument), Personal (Services, Instrument), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Noninvasive Prenatal Diagnostics.
Regionally, the report analyzes the Noninvasive Prenatal Diagnostics markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Noninvasive Prenatal Diagnostics market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Noninvasive Prenatal Diagnostics market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Noninvasive Prenatal Diagnostics industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Services, Instrument).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Noninvasive Prenatal Diagnostics market.
Regional Analysis: The report involves examining the Noninvasive Prenatal Diagnostics market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Noninvasive Prenatal Diagnostics market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Noninvasive Prenatal Diagnostics:
Company Analysis: Report covers individual Noninvasive Prenatal Diagnostics players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Noninvasive Prenatal Diagnostics This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Personal).
Technology Analysis: Report covers specific technologies relevant to Noninvasive Prenatal Diagnostics. It assesses the current state, advancements, and potential future developments in Noninvasive Prenatal Diagnostics areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Noninvasive Prenatal Diagnostics market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Noninvasive Prenatal Diagnostics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Services
Instrument
Market segment by Application
Hospital
Personal
Other
Market segment by players, this report covers
Natera
Illumina
BGI Diagnosis
Ariosa Diagnostics
Quest Diagnostics
Premaitha Health
NIPD Genetics
Labcorp
Ravgen
LifeCodexx
TrovaGene
Berry Genomics
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Noninvasive Prenatal Diagnostics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Noninvasive Prenatal Diagnostics, with revenue, gross margin and global market share of Noninvasive Prenatal Diagnostics from 2019 to 2024.
Chapter 3, the Noninvasive Prenatal Diagnostics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Noninvasive Prenatal Diagnostics market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Noninvasive Prenatal Diagnostics.
Chapter 13, to describe Noninvasive Prenatal Diagnostics research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Noninvasive Prenatal Diagnostics
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Noninvasive Prenatal Diagnostics by Type
    • 1.3.1 Overview: Global Noninvasive Prenatal Diagnostics Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global Noninvasive Prenatal Diagnostics Consumption Value Market Share by Type in 2023
    • 1.3.3 Services
    • 1.3.4 Instrument
  • 1.4 Global Noninvasive Prenatal Diagnostics Market by Application
    • 1.4.1 Overview: Global Noninvasive Prenatal Diagnostics Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Hospital
    • 1.4.3 Personal
    • 1.4.4 Other
  • 1.5 Global Noninvasive Prenatal Diagnostics Market Size & Forecast
  • 1.6 Global Noninvasive Prenatal Diagnostics Market Size and Forecast by Region
    • 1.6.1 Global Noninvasive Prenatal Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global Noninvasive Prenatal Diagnostics Market Size by Region, (2019-2030)
    • 1.6.3 North America Noninvasive Prenatal Diagnostics Market Size and Prospect (2019-2030)
    • 1.6.4 Europe Noninvasive Prenatal Diagnostics Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific Noninvasive Prenatal Diagnostics Market Size and Prospect (2019-2030)
    • 1.6.6 South America Noninvasive Prenatal Diagnostics Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East and Africa Noninvasive Prenatal Diagnostics Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 Natera
    • 2.1.1 Natera Details
    • 2.1.2 Natera Major Business
    • 2.1.3 Natera Noninvasive Prenatal Diagnostics Product and Solutions
    • 2.1.4 Natera Noninvasive Prenatal Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Natera Recent Developments and Future Plans
  • 2.2 Illumina
    • 2.2.1 Illumina Details
    • 2.2.2 Illumina Major Business
    • 2.2.3 Illumina Noninvasive Prenatal Diagnostics Product and Solutions
    • 2.2.4 Illumina Noninvasive Prenatal Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Illumina Recent Developments and Future Plans
  • 2.3 BGI Diagnosis
    • 2.3.1 BGI Diagnosis Details
    • 2.3.2 BGI Diagnosis Major Business
    • 2.3.3 BGI Diagnosis Noninvasive Prenatal Diagnostics Product and Solutions
    • 2.3.4 BGI Diagnosis Noninvasive Prenatal Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 BGI Diagnosis Recent Developments and Future Plans
  • 2.4 Ariosa Diagnostics
    • 2.4.1 Ariosa Diagnostics Details
    • 2.4.2 Ariosa Diagnostics Major Business
    • 2.4.3 Ariosa Diagnostics Noninvasive Prenatal Diagnostics Product and Solutions
    • 2.4.4 Ariosa Diagnostics Noninvasive Prenatal Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Ariosa Diagnostics Recent Developments and Future Plans
  • 2.5 Quest Diagnostics
    • 2.5.1 Quest Diagnostics Details
    • 2.5.2 Quest Diagnostics Major Business
    • 2.5.3 Quest Diagnostics Noninvasive Prenatal Diagnostics Product and Solutions
    • 2.5.4 Quest Diagnostics Noninvasive Prenatal Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Quest Diagnostics Recent Developments and Future Plans
  • 2.6 Premaitha Health
    • 2.6.1 Premaitha Health Details
    • 2.6.2 Premaitha Health Major Business
    • 2.6.3 Premaitha Health Noninvasive Prenatal Diagnostics Product and Solutions
    • 2.6.4 Premaitha Health Noninvasive Prenatal Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Premaitha Health Recent Developments and Future Plans
  • 2.7 NIPD Genetics
    • 2.7.1 NIPD Genetics Details
    • 2.7.2 NIPD Genetics Major Business
    • 2.7.3 NIPD Genetics Noninvasive Prenatal Diagnostics Product and Solutions
    • 2.7.4 NIPD Genetics Noninvasive Prenatal Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 NIPD Genetics Recent Developments and Future Plans
  • 2.8 Labcorp
    • 2.8.1 Labcorp Details
    • 2.8.2 Labcorp Major Business
    • 2.8.3 Labcorp Noninvasive Prenatal Diagnostics Product and Solutions
    • 2.8.4 Labcorp Noninvasive Prenatal Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Labcorp Recent Developments and Future Plans
  • 2.9 Ravgen
    • 2.9.1 Ravgen Details
    • 2.9.2 Ravgen Major Business
    • 2.9.3 Ravgen Noninvasive Prenatal Diagnostics Product and Solutions
    • 2.9.4 Ravgen Noninvasive Prenatal Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Ravgen Recent Developments and Future Plans
  • 2.10 LifeCodexx
    • 2.10.1 LifeCodexx Details
    • 2.10.2 LifeCodexx Major Business
    • 2.10.3 LifeCodexx Noninvasive Prenatal Diagnostics Product and Solutions
    • 2.10.4 LifeCodexx Noninvasive Prenatal Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 LifeCodexx Recent Developments and Future Plans
  • 2.11 TrovaGene
    • 2.11.1 TrovaGene Details
    • 2.11.2 TrovaGene Major Business
    • 2.11.3 TrovaGene Noninvasive Prenatal Diagnostics Product and Solutions
    • 2.11.4 TrovaGene Noninvasive Prenatal Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 TrovaGene Recent Developments and Future Plans
  • 2.12 Berry Genomics
    • 2.12.1 Berry Genomics Details
    • 2.12.2 Berry Genomics Major Business
    • 2.12.3 Berry Genomics Noninvasive Prenatal Diagnostics Product and Solutions
    • 2.12.4 Berry Genomics Noninvasive Prenatal Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.12.5 Berry Genomics Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Noninvasive Prenatal Diagnostics Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of Noninvasive Prenatal Diagnostics by Company Revenue
    • 3.2.2 Top 3 Noninvasive Prenatal Diagnostics Players Market Share in 2023
    • 3.2.3 Top 6 Noninvasive Prenatal Diagnostics Players Market Share in 2023
  • 3.3 Noninvasive Prenatal Diagnostics Market: Overall Company Footprint Analysis
    • 3.3.1 Noninvasive Prenatal Diagnostics Market: Region Footprint
    • 3.3.2 Noninvasive Prenatal Diagnostics Market: Company Product Type Footprint
    • 3.3.3 Noninvasive Prenatal Diagnostics Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Noninvasive Prenatal Diagnostics Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global Noninvasive Prenatal Diagnostics Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global Noninvasive Prenatal Diagnostics Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global Noninvasive Prenatal Diagnostics Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America Noninvasive Prenatal Diagnostics Consumption Value by Type (2019-2030)
  • 6.2 North America Noninvasive Prenatal Diagnostics Consumption Value by Application (2019-2030)
  • 6.3 North America Noninvasive Prenatal Diagnostics Market Size by Country
    • 6.3.1 North America Noninvasive Prenatal Diagnostics Consumption Value by Country (2019-2030)
    • 6.3.2 United States Noninvasive Prenatal Diagnostics Market Size and Forecast (2019-2030)
    • 6.3.3 Canada Noninvasive Prenatal Diagnostics Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico Noninvasive Prenatal Diagnostics Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe Noninvasive Prenatal Diagnostics Consumption Value by Type (2019-2030)
  • 7.2 Europe Noninvasive Prenatal Diagnostics Consumption Value by Application (2019-2030)
  • 7.3 Europe Noninvasive Prenatal Diagnostics Market Size by Country
    • 7.3.1 Europe Noninvasive Prenatal Diagnostics Consumption Value by Country (2019-2030)
    • 7.3.2 Germany Noninvasive Prenatal Diagnostics Market Size and Forecast (2019-2030)
    • 7.3.3 France Noninvasive Prenatal Diagnostics Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom Noninvasive Prenatal Diagnostics Market Size and Forecast (2019-2030)
    • 7.3.5 Russia Noninvasive Prenatal Diagnostics Market Size and Forecast (2019-2030)
    • 7.3.6 Italy Noninvasive Prenatal Diagnostics Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific Noninvasive Prenatal Diagnostics Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific Noninvasive Prenatal Diagnostics Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific Noninvasive Prenatal Diagnostics Market Size by Region
    • 8.3.1 Asia-Pacific Noninvasive Prenatal Diagnostics Consumption Value by Region (2019-2030)
    • 8.3.2 China Noninvasive Prenatal Diagnostics Market Size and Forecast (2019-2030)
    • 8.3.3 Japan Noninvasive Prenatal Diagnostics Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea Noninvasive Prenatal Diagnostics Market Size and Forecast (2019-2030)
    • 8.3.5 India Noninvasive Prenatal Diagnostics Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia Noninvasive Prenatal Diagnostics Market Size and Forecast (2019-2030)
    • 8.3.7 Australia Noninvasive Prenatal Diagnostics Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America Noninvasive Prenatal Diagnostics Consumption Value by Type (2019-2030)
  • 9.2 South America Noninvasive Prenatal Diagnostics Consumption Value by Application (2019-2030)
  • 9.3 South America Noninvasive Prenatal Diagnostics Market Size by Country
    • 9.3.1 South America Noninvasive Prenatal Diagnostics Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil Noninvasive Prenatal Diagnostics Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina Noninvasive Prenatal Diagnostics Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa Noninvasive Prenatal Diagnostics Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa Noninvasive Prenatal Diagnostics Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa Noninvasive Prenatal Diagnostics Market Size by Country
    • 10.3.1 Middle East & Africa Noninvasive Prenatal Diagnostics Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey Noninvasive Prenatal Diagnostics Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia Noninvasive Prenatal Diagnostics Market Size and Forecast (2019-2030)
    • 10.3.4 UAE Noninvasive Prenatal Diagnostics Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 Noninvasive Prenatal Diagnostics Market Drivers
  • 11.2 Noninvasive Prenatal Diagnostics Market Restraints
  • 11.3 Noninvasive Prenatal Diagnostics Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Noninvasive Prenatal Diagnostics Industry Chain
  • 12.2 Noninvasive Prenatal Diagnostics Upstream Analysis
  • 12.3 Noninvasive Prenatal Diagnostics Midstream Analysis
  • 12.4 Noninvasive Prenatal Diagnostics Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Noninvasive Prenatal Diagnostics. Industry analysis & Market Report on Noninvasive Prenatal Diagnostics is a syndicated market report, published as Global Noninvasive Prenatal Diagnostics Market 2024 by Company, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Noninvasive Prenatal Diagnostics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,651.76
    		3,977.64
    		5,303.52
    		3,138.96
    		4,708.44
    		6,277.92
    		490,540.80
    		735,811.20
    		981,081.60
    		292,180.80
    		438,271.20
    		584,361.60
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo